These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Understanding the Cause and Consequence of Tumor Heterogeneity. Khatib S; Pomyen Y; Dang H; Wang XW Trends Cancer; 2020 Apr; 6(4):267-271. PubMed ID: 32209440 [TBL] [Abstract][Full Text] [Related]
5. Molecular pathways and therapeutic targets in lung cancer. Shtivelman E; Hensing T; Simon GR; Dennis PA; Otterson GA; Bueno R; Salgia R Oncotarget; 2014 Mar; 5(6):1392-433. PubMed ID: 24722523 [TBL] [Abstract][Full Text] [Related]
6. Autophagy-associated targeting pathways of natural products during cancer treatment. Zhang SF; Wang XL; Yang XQ; Chen N Asian Pac J Cancer Prev; 2014; 15(24):10557-63. PubMed ID: 25605139 [TBL] [Abstract][Full Text] [Related]
7. STAT proteins as novel targets for cancer drug discovery. Turkson J Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392 [TBL] [Abstract][Full Text] [Related]
8. Somatic alterations as the basis for resistance to targeted therapies. Blair BG; Bardelli A; Park BH J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654 [TBL] [Abstract][Full Text] [Related]
9. Targeting the mTOR pathway in tumor malignancy. Cheng H; Walls M; Baxi SM; Yin MJ Curr Cancer Drug Targets; 2013 Mar; 13(3):267-77. PubMed ID: 23297825 [TBL] [Abstract][Full Text] [Related]
10. Broad targeting of resistance to apoptosis in cancer. Mohammad RM; Muqbil I; Lowe L; Yedjou C; Hsu HY; Lin LT; Siegelin MD; Fimognari C; Kumar NB; Dou QP; Yang H; Samadi AK; Russo GL; Spagnuolo C; Ray SK; Chakrabarti M; Morre JD; Coley HM; Honoki K; Fujii H; Georgakilas AG; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich WG; Yang X; Boosani CS; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Mohammed SI; Keith WN; Bilsland A; Halicka D; Nowsheen S; Azmi AS Semin Cancer Biol; 2015 Dec; 35 Suppl(0):S78-S103. PubMed ID: 25936818 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Surh YJ; Chun KS; Cha HH; Han SS; Keum YS; Park KK; Lee SS Mutat Res; 2001 Sep; 480-481():243-68. PubMed ID: 11506818 [TBL] [Abstract][Full Text] [Related]
12. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559 [TBL] [Abstract][Full Text] [Related]
13. Broad targeting of angiogenesis for cancer prevention and therapy. Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy. Hua H; Kong Q; Yin J; Zhang J; Jiang Y J Hematol Oncol; 2020 Jun; 13(1):64. PubMed ID: 32493414 [TBL] [Abstract][Full Text] [Related]
15. A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality. Parameswaran S; Kundapur D; Vizeacoumar FS; Freywald A; Uppalapati M; Vizeacoumar FJ Trends Cancer; 2019 Jan; 5(1):11-29. PubMed ID: 30616753 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor as a therapeutic target in glioblastoma. Kalman B; Szep E; Garzuly F; Post DE Neuromolecular Med; 2013 Jun; 15(2):420-34. PubMed ID: 23575987 [TBL] [Abstract][Full Text] [Related]
17. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Shapira A; Livney YD; Broxterman HJ; Assaraf YG Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory Process and Molecular Targets for Antiinflammatory Nutraceuticals. Huang MT; Ghai G; Ho CT Compr Rev Food Sci Food Saf; 2004 Oct; 3(4):127-139. PubMed ID: 33430565 [TBL] [Abstract][Full Text] [Related]
19. Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations. Chan MM; Chen R; Fong D Cancer Lett; 2018 Oct; 433():53-64. PubMed ID: 29960048 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of chromatin: status and opportunities. Siklos M; Kubicek S FEBS J; 2022 Mar; 289(5):1276-1301. PubMed ID: 33982887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]